{"title": "INFECCI\u00d3N POR VIRUS DEL PAPILOMA HUMANO Y C\u00c1NCER DE CUELLO UTERINO", "author": "Jairo Reynales Londo\u00f1o", "url": null, "hostname": null, "description": "RESUMENIntroducci\u00f3n. Se revis\u00f3 la situaci\u00f3n actual de la infecci\u00f3n por Virus del Papiloma Humano y su relaci\u00f3n con el C\u00e1ncer de Cuello Uterino.M\u00e9todos. La metodolog\u00eda se bas\u00f3 en la revisi\u00f3n sistem\u00e1tica de art\u00edculos originales que analizaron aspectos relacionados con esta infecci\u00f3n viral y el c\u00e1ncer de c\u00e9rvix, las pruebas de tamizaje, las acciones que se adelantan y la vacuna contra el virus del papiloma humano.Resultados. Factores como falta de voluntad pol\u00edtica para aunar esfuerzos, barreras de acceso generadas a las usuarias, falta de adecuaci\u00f3n de los servicios, la estructura y organizaci\u00f3n del Sistema General de Seguridad Social en Salud, pueden explicar la poca reducci\u00f3n en mortalidad por esta malignidad, a pesar de existir pol\u00edticas p\u00fablicas y reglamentaci\u00f3n en Colombia. Desde la reforma de 1993, el control de las enfermedades de inter\u00e9s en salud p\u00fablica ha sido insuficiente.Discusi\u00f3n. La alta morbimortalidad impone urgentemente a los diferentes actores del sector sanitario la implementaci\u00f3n de precisas medidas preventivas y terap\u00e9uticas ya conocidas para controlar el c\u00e1ncer de c\u00e9rvix, as\u00ed como la evaluaci\u00f3n de nuevas intervenciones.Palabras clave: Virus del Papiloma Humano (VPH), C\u00e1ncer de Cuello Uterino (CCU), c\u00e1ncer de c\u00e9rvix, tamizaje cervical, vacunas VPH.HUMAN PAPILLOMA VIRUS INFECTION AND CERVICAL UTERINE CANCERABSTRACTIntroduction. A literature review of current aspects of Papilloma Virus Infection and its relationship with Uterine Cervical Cancer was undertaken. Methods. The systematic review concerned original papers analyzing aspects related to this viral infection and cervical uterine cancer, screening tests, actions taken and human papilloma virus vaccines. Results. Little attention is paid to cervical cancer by health officials; there are access barriers to users, inadequate health services, an inflexible structure and organization of Health Social Security General System, uncoordinated efforts, all of which could explain the little reduction in mortality; in spite of the existence of a public policy and regulations on screening tests, a clear-cut political attitude by different system actors is not seen. Since 1993 health reform, there has been insufficient interest in controlling public health conditions. Discussion. Urgent actions should be taken by health officials to control high morbidity and mortality related to cervical cancer with known existing preventive and therapeutic measures; forthcoming interventions must be evaluated as well.Key words: Human papilloma virus (HPV), uterine cervical carcinoma, cervix cancer, HPV vaccines.", "sitename": "Medicina", "date": "2012-09-09", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "INFECCI\u00d3N POR VIRUS DEL PAPILOMA HUMANO Y C\u00c1NCER DE CUELLO UTERINO\nPalabras clave:Virus del Papiloma Humano (VPH), C\u00e1ncer de Cuello Uterino (CCU), c\u00e1ncer de c\u00e9rvix, tamizaje cervical, vacunas VPH, Human papilloma virus (HPV), uterine cervical carcinoma, cervix cancer, HPV vaccines.\nResumenRESUMEN\nIntroducci\u00f3n. Se revis\u00f3 la situaci\u00f3n actual de la infecci\u00f3n por Virus del Papiloma Humano y su relaci\u00f3n con el C\u00e1ncer de Cuello Uterino.\nM\u00e9todos. La metodolog\u00eda se bas\u00f3 en la revisi\u00f3n sistem\u00e1tica de art\u00edculos originales que analizaron aspectos relacionados con esta infecci\u00f3n viral y el c\u00e1ncer de c\u00e9rvix, las pruebas de tamizaje, las acciones que se adelantan y la vacuna contra el virus del papiloma humano.\nResultados. Factores como falta de voluntad pol\u00edtica para aunar esfuerzos, barreras de acceso generadas a las usuarias, falta de adecuaci\u00f3n de los servicios, la estructura y organizaci\u00f3n del Sistema General de Seguridad Social en Salud, pueden explicar la poca reducci\u00f3n en mortalidad por esta malignidad, a pesar de existir pol\u00edticas p\u00fablicas y reglamentaci\u00f3n en Colombia. Desde la reforma de 1993, el control de las enfermedades de inter\u00e9s en salud p\u00fablica ha sido insuficiente.\nDiscusi\u00f3n. La alta morbimortalidad impone urgentemente a los diferentes actores del sector sanitario la implementaci\u00f3n de precisas medidas preventivas y terap\u00e9uticas ya conocidas para controlar el c\u00e1ncer de c\u00e9rvix, as\u00ed como la evaluaci\u00f3n de nuevas intervenciones.\nPalabras clave: Virus del Papiloma Humano (VPH), C\u00e1ncer de Cuello Uterino (CCU), c\u00e1ncer de c\u00e9rvix, tamizaje cervical, vacunas VPH.HUMAN PAPILLOMA VIRUS INFECTION AND CERVICAL UTERINE CANCERABSTRACT\nIntroduction. A literature review of current aspects of Papilloma Virus Infection and its relationship with Uterine Cervical Cancer was undertaken. Methods. The systematic review concerned original papers analyzing aspects related to this viral infection and cervical uterine cancer, screening tests, actions taken and human papilloma virus vaccines. Results. Little attention is paid to cervical cancer by health officials; there are access barriers to users, inadequate health services, an inflexible structure and organization of Health Social Security General System, uncoordinated efforts, all of which could explain the little reduction in mortality; in spite of the existence of a public policy and regulations on screening tests, a clear-cut political attitude by different system actors is not seen. Since 1993 health reform, there has been insufficient interest in controlling public health conditions. Discussion. Urgent actions should be taken by health officials to control high morbidity and mortality related to cervical cancer with known existing preventive and therapeutic measures; forthcoming interventions must be evaluated as well.\nKey words: Human papilloma virus (HPV), uterine cervical carcinoma, cervix cancer, HPV vaccines.\nDescargas\nReferencias bibliogr\u00e1ficas\nAral SO, Holmes KK. Social and behavioral determinants of epidemiology of STDs: industrialized\nand developing countries. En: Holmes K, Mardh PA, Sparling PF, et al. Sexually Trans-mitted Diseases. New York: McGraw-Hill, 1999; 39-76.\nBurchell AN, Winer RL, de San Jos\u00e9 S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006 Aug 21; 24 Suppl 3:S52-61.\nGlobocan, Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. 2004, IARC Lyon.\nProfamilia. Encuesta Nacional de Demograf\u00eda y Salud 2005. Bogot\u00e1: Profamilia; 2005.\nProfamilia. Encuesta Nacional de Demograf\u00eda y Salud 2010. Bogot\u00e1: Profamilia; 2010.\nMinisterio de Salud, Centro Nacional de Consultor\u00eda. Conocimientos, actitudes y pr\u00e1cticas en detecci\u00f3n temprana de c\u00e1ncer c\u00e9rvico-uterino y de mama. II Estudio Nacional de Factores de Riesgo de Enfermedades Cr\u00f3nicas (ENFREC II). Tomo IV. Bogot\u00e1 D. C.: Ministerio de Salud; 1999.\nOjeda G, Ord\u00f3\u00f1ez M, Ochoa L, Samper B, S\u00e1nchez F. Salud sexual y reproductiva: Resultados Encuesta Nacional de Demograf\u00eda y Salud 2005. Asociaci\u00f3n Probienestar de la Familia Colombiana (Profamilia). Patrocinado por Profamilia, Bienestar Familiar, United State Agency for Internacional Development, Ministerio de la Protecci\u00f3n Social; Noviembre de 2005.\nFerlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base N\u00b0 5, version 2.0 IARC Press, Lyon; 2004.\nRealpe C, Escobar GM, Largo B, Duque B. Utilizaci\u00f3n del programa de promoci\u00f3n y prevenci\u00f3n en las empresas promotoras de salud y administradoras del r\u00e9gimen subsidiado de Manizales, Colombia, 2001-2002. Colombia M\u00e9dica 2002; 33 (3): 102-107.\nRam\u00edrez H, V\u00e9lez S, Vargas V, S\u00e1nchez C, Lopera J. Evaluaci\u00f3n de la cobertura en aseguramiento y accesibilidad a los servicios de salud de los afiliados al r\u00e9gimen subsidiado en el municipio de Medell\u00edn. Colombia M\u00e9dica 2001; 32: 10-13.\nMart\u00ednez P, Rodr\u00edguez L, Agudelo C. Equidad en la pol\u00edtica de la reforma del sistema de salud. Rev. Salud P\u00fablica (Colombia). 2001; 3: 19-39.\nSawaya GF, Brown AD, Washington AE, Garber AM. Clinical practice. Current approaches to cervicalcancer screening. N Eng J Med 2001;344:1603-7.\nSelvaggi SM. Implications of low diagnostic reproducibility of cervical cytologic and histologic diagnosis.\nJAMA 2001; 285:1506-7. Citado en Ortiz Serrano Ricardo, Uribe P\u00e9rez Claudia Janeth, D\u00edaz Mart\u00ednez Luis Alfonso, Yuriko Rafael. Factores de riesgo para c\u00e1ncer de cuello uterino. Rev Colomb Obstet Ginecol [peri\u00f3dico na Internet]. 2004 Jun [citado 2012 Jul 20]; 55(2): 146-160.\nWiesner C, Tovar S, Cendales R, Vejarano M. Organizaci\u00f3n de los servicios de salud para el control del c\u00e1ncer de cuello uterino en el Municipio de Soacha. Rev. Colomb Cancerol 2006; 10(2):98-108.\nMedeiros LR, Dornelles D, da Rosa MI, Bozzetti MC, Ruviaro R, Efficacy of Human Papillomavirus Vaccine. Int J Gynecol Cancer 2009; 19: 1166-1176.\nHarper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. HPV Vaccine Study group. Sustained efficacy up to 4.5 years of a bivalent L1 viruslike particle vaccine against human papillomavirus types 16 and 18: follow up from a randomized trial. Lancet. 2006; 367:1247-1255.\nKoutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; Nov 21;347 (21):1645-51.\nVilla LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; May;6(5):271-8.\nMao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, et. al. Efficacy of human papillomavirus- 16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2006;107(1):18-27.\nSteinbrook R. The potential of human papillomavirus vaccines. N Eng J Med 2006; 354(11):1109\u20131112.\nLizcano et al. Infecci\u00f3n por virus del Papiloma Humano: Epidemiolog\u00eda, Historia Natural y Carcinog\u00e9nesis. INS M\u00e9xico. Cancerolog\u00eda 4 (2009); 205-216.\nMolano M, Posso H, M\u00e9ndez F, Murillo R, van den Brule A, Ronderos M, et al. Historia natural de la infecci\u00f3n por el virus del papiloma humano en una cohorte de mujeres de Bogot\u00e1. Rev. Colomb Cancerol. 2005; 9:192-209.\nCastellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008; 110:S4-S7\nSchlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. J Am Med Assoc 2001; 286:3106-3114.\nCastellsague X, Munoz N. Chapter 3. Cofactors in human papillomavirus carcinogenesis. Role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 20-28.\nGarcia-Closas R, Castellsague, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence. Int J Cancer 2005; 117:629-37.\nSchiffman M, Kruger Kjaer S. Natural history of anogenital human papillomavirus infection and neoplasia. JNCI Monographs, 2003; 31:14-19.\nSteenbergen RDM, de Wilde J, Wilting SM, Brink AATP, Snijders PJF, Meijer CJLM. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005; 32S: S25-S33.\nSchiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337(1): 76-84.\nKoshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008; 168(2):123\u201337. Epub 2008 May 15.\nSmith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121(3): 621-32.\nMoscicki AB, Schiffman M, Kjaer S, Villa L. Updatingthe natural history of HPV and anogenital cancer, Vaccine 2006; 24S3: S3/42-S3/51.\nBosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infection and typespecific implications in cervical neoplasia. Vaccine 2008; 26S: k1-k16.\nWoodman Ciaran B J, Collins S I, Young L S. The natural history of cervical HPV infection: unresolved issues. Nature Reviews, 2007; vol.7: 11-22.\nGeneralitat de Catalunya. Protocolo de las actividades para el cribado del c\u00e1ncer del cuello uterino en la atenci\u00f3n primaria. Plan Director de Oncolog\u00eda. Instituto Catalan de Oncolog\u00eda. 2006.\nBosch FX, Manos MM, Mu\u00f1oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87(11): 796-802.\nGlobocan, Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. 2004, IARC Lyon. 38. Stanley M, Lowy D, Frazer I. Vacunas profil\u00e1cticas contra el VPH. Vaccine, 2006; 24(S3): 113-121.\nBosch FX, Lorincz A, Mu\u00f1oz N, Meijer CJ, Shah KV. The causal relation between Human Papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-65.\nIsaza-Ruget, Mario Arturo, P\u00e9rez, Gonzalo, Morales- Reyes, Olga Luc\u00eda et al. Exactitud del test ADN-HPV para la detecci\u00f3n de la enfermedad cervical de alto grado (NIC 2+) en mujeres con anormalidades citol\u00f3gicas (ASC-US y LSIL), afiliadas a la seguridad social en Bogot\u00e1 (Colombia). Rev Colomb Obstet Ginecol, 2009; 60 (3) 213-222.\nFerlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality, and prevalence worldwide. Lyon: IARC Press; 2002.__\nKitchener HC, Castle PE, Cox JT. Achievements and limitations of cervical cytology screening. Vaccine. 2006; 24 suppl 3:S3/63-70.\nMcCrory DC; Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, Myers, E, Nanda K. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment N\u00b0 5. (Prepared by Duke University). AHCPR Publication N\u00b099-E010. Rockville, MD. Agency for Health Care Policy and Research, U.S.\nDepartment of Health and Human Services, February, 1999. Citado en D\u00edaz M.C, Parra E.A Gu\u00eda de Control de Calidad para la toma, procesamiento e interpretaci\u00f3n en muestras de citolog\u00eda de cuello uterino. Convenio 043 MPS-INS, Bogot\u00e1, D. C., 2008.\nSankaranarayanan R, Somanathan T, Sharma A, Roy C, Shastri S, Mahe C, et al. Accuracy of conventional cytology: Results from a multicenter screening study in India. J Med Screen. 2004; 11(2):77-84. Citado en D\u00edaz M.C, Parra E.A Gu\u00eda de Control de Calidad para la toma, procesamiento e interpretaci\u00f3n en muestras de citolog\u00eda de cuello uterino. Convenio 043 MPS-INS, Bogot\u00e1, D. C., 2008.\nCort\u00e9s, C. Programas para el control del c\u00e1ncer de cuello uterino. An\u00e1lisis sociopol\u00edtico 1975-1995. Tesis de MSP, U Nacional\n[http://www.bdigital.unal](http://www.bdigital.unal). edu.co/664/1/597351.2007.pdf\nWiesner C, Tovar S, Pi\u00f1eros M, Cendales R, Murillo R. La oferta de servicios para tamizaci\u00f3n de c\u00e1ncer de cuello uterino en Colombia. Rev Colomb Cancerol 2009; 13(3):134-144.\nMeijer C, Berkhof J, Castle P E, Hesselink AT Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women years and older. Int J Cancer 2009; 124: 516-20.\nGravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutl\u00e9e F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.\nMurillo R, Pi\u00f1eros M, Hern\u00e1ndez G. Atlas de mortalidad por c\u00e1ncer en Colombia. Bogot\u00e1: Instituto Nacional de Cancerolog\u00eda-Instituto Geogr\u00e1fico Agust\u00edn Codazzi; 2004.\nMurillo R, Almonte M, Pereira A, Ferrer E, Gamboa O, Jer\u00f3nimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine. 2008; 26(Suppl.11):L37-48.\nPi\u00f1eros M, Cendales R, Murillo R, Wiesner C, Tovar S. Cobertura de la citolog\u00eda de cuello uterino y factores relacionados en Colombia, 2005. Rev Salud P\u00fablica. (Bogot\u00e1) 2007; 9:327-41.\nWiesner C, Murillo RH, Pi\u00f1eros M, Tovar SL, Cendales R, Guti\u00e9rrez MC. Control del c\u00e1ncer cervicouterino en Colombia: la perspectiva de los actores del sistema de salud. Rev. Panam Salud P\u00fablica [serial on the Internet]. 2009 Jan [cited 2010 Nov 22]; 25(1): 1-8.\nGamboa OA, Chica\u00edza L, Garc\u00eda-Molina M, D\u00edaz J, Gonz\u00e1lez M, Murillo R, et al. Cost-effectiveness of conventional cytology and HPV-DNA testing for cervical-cancer screening in Colombia. Salud Pub Mex. 2008; 50:276-85.\nGoldie SJ, Kim JJ, Myers E. Chapter 19: Costeffectiveness of cervical cancer screening. Vaccine 2006; 24 (Suppl. 3):S164-70.\nMandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefit and costs of using PVH testing to screen for cervical cancer. JAMA. 2002; 287:2372-81.\nGoldie SJ. Chapter 15: Public health policy and costeffectiveness analysis. JNatl Cancer Inst Monogr. 2003; 31:102-10.\nGoldie SJ. Health economics and cervical cancer prevention: a global perspective. Virus Res. 2002; 89:301-9.\nSuba EJ, Murphy SK, Donnelly AD, Furia LM, Huynh ML, Raab SS. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health. 2006; 96:480-7.\nGoldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004; 103:619-31.\nKim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst. 2005; 97:888-95.\nWright TC Jr, Schiffman M, Solomon D, Thomas JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004; 103:304-9.\nKim JJ, Wright TC, Goldie SJ. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002; 287:2382-90.\nGoldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo- Tobar A, Levin C, Mah\u00e9 C, et al. Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med. 2005; 353:2158-68.\nAurelio Mej\u00eda, Walter Salas. Costo-efectividad de la detecci\u00f3n del virus del papiloma humano en los programas de tamizaci\u00f3n de c\u00e1ncer de cuello uterino. Biom\u00e9dica vol.28 N\u00b01 Bogot\u00e1 Jan. /Mar. 2008.\nMinisterio de Salud. Resoluci\u00f3n 4288 de 1996, por la cual se define el Plan de Atenci\u00f3n B\u00e1sica (PAB) del Sistema General de Seguridad Social (SGSSS) y se dictan otras disposiciones. Bogot\u00e1 D.C. Ministerio de Salud de la Protecci\u00f3n Social; 2004.\nWiesner-Ceballos C, Murillo-Moreno RH, Pi\u00f1eros- Petersen M, Tovar-Murillo SL, Cendales-Duarte R, Guti\u00e9rrez MC. Control del c\u00e1ncer cervicouterino en Colombia: la perspectiva de los actores del sistema de salud. Rev. Panam Salud P\u00fablica. 2009; 25(1):1-8.\nAlianza para la Prevenci\u00f3n del C\u00e1ncer Cervicouterino (ACCP). Planificaci\u00f3n y aplicaci\u00f3n de los programas de prevenci\u00f3n y control de c\u00e1ncer cervicouterino: Manual para gestores. Seattle: ACCP; 2006. 72 p.\nPi\u00f1eros M, Cendales R, Murillo R, Wiesner C, TovarS. Pap test coverage and related factors in Colombia 2005. Rev. Salud P\u00fablica [Bogot\u00e1]. 2007; 9(3):327- 41.\nNubia Mu\u00f1oz, MD, MPH, Dr. Sc, Julio C\u00e9sar Reina, MD, Gloria In\u00e9s S\u00e1nchez, MSc, PhD. La vacuna contra el virus del papiloma humano: una gran arma para la prevenci\u00f3n primaria del c\u00e1ncer de cuello uterino. Colomb Med. 2008; 39: 196-204.\nKATIA ABARCA V MD. Infecci\u00f3n por virus papiloma humano y c\u00e1ncer cervicouterino: \u00bfEn las puertas de la prevenci\u00f3n? Bol escuela de medicina U.C., Pontificia Universidad Cat\u00f3lica de Chile vol. 32 N\u00ba1:25-27. 2007.\nRep\u00fablica de Colombia, Ministerio de Salud. Resoluci\u00f3n 3384 de 2000. \u201cPor la que se modifican parcialmente las Resoluciones 412 y 1745 de 2000 y se deroga la Resoluci\u00f3n 1078 de 2000\u201d. Bogot\u00e1: Ministerio de Salud, 2000.\nNubia Mu\u00f1oz, MD, MPH, Dr. Sc, Julio C\u00e9sar Reina, MD, Gloria In\u00e9s S\u00e1nchez, MSc, PhD. La vacuna contrael virus del papiloma humano: una gran arma para la prevenci\u00f3n primaria del c\u00e1ncer de cuello uterino. Colomb Med. 2008; 39: 196-204.\nAssalud. Dise\u00f1o y aplicaci\u00f3n de una encuesta para la evaluaci\u00f3n de las acciones de prevenci\u00f3n y promoci\u00f3n del Plan Obligatorio de Salud de los reg\u00edmenes Contributivo y Subsidiado y del logro de las metas del Plan de Atenci\u00f3n B\u00e1sica PAB- Departamental y Distrital. Bogot\u00e1: Assalud; 2004.\nOMS. Documento de posici\u00f3n. Vacunas contra el virus del papiloma humano. N\u00b0 15. 10 de abril de 2009, 84, 117\u2013132.\nRep\u00fablica de Colombia, Ministerio de la Protecci\u00f3n Social. Circular N\u00b0 0018 de 2004. \u201cPor la cual se definen los lineamientos para la formulaci\u00f3n y ejecuci\u00f3n de los planes estrat\u00e9gicos y operativos del Plan de Atenci\u00f3n B\u00e1sica (PAB) y de los recursos asignados para salud p\u00fablica 2004-2007\u201d. Bogot\u00e1: Ministerio de Salud, 2004.\nRep\u00fablica de Colombia, Ministerio de Salud. Consejo Nacional de Seguridad Social en Salud. Acuerdo N\u00b0117 de 1998. \u201cPor el cual se establece el obligatorio cumplimiento de las actividades, procedimientos e intervenciones de demanda inducida y la atenci\u00f3n de enfermedades de inter\u00e9s en salud p\u00fablica\u201d. Bogot\u00e1: Ministerio de Salud, 1998.\nRep\u00fablica de Colombia, Ministerio de Salud. Resoluci\u00f3n N\u00b0 5261 de 1994. \u201cPor la cual se establece\nel manual de actividades, intervenciones y procedimientos del Plan Obligatorio de Salud -POS- del SGSSS\u201d. Bogot\u00e1: Ministerio de Salud, 1994.\nRep\u00fablica de Colombia, Ministerio de Salud. Resoluci\u00f3n N\u00b0 412 del 28 de febrero de 2000. \u201cPor la cual se establecen las actividades, procedimientos e intervenciones de demanda inducida y obligatorio cumplimiento\u201d. Bogot\u00e1: Ministerio de Salud, 2000.\nRep\u00fablica de Colombia, Congreso de la Rep\u00fablica. Ley 715 de 2001. \u201cPor la cual se dictan normas org\u00e1nicas en materia de recursos y competencias, para organizar la prestaci\u00f3n de los servicios de educaci\u00f3n y salud, entre otros\u201d. Bogot\u00e1: Congreso de la Rep\u00fablica de Colombia, 2001.\nRep\u00fablica de Colombia, Ministerio de Salud. Consejo Nacional de Seguridad Social en Salud. Acuerdo N\u00b0 229 de 2002. \u201cPor el cual se define la proporci\u00f3n de la UPC-S que se destinar\u00e1 para la financiaci\u00f3n de las acciones de promoci\u00f3n y prevenci\u00f3n, entre otros\u201d. Bogot\u00e1: Ministerio de Salud, 2002.\nDescargas\nPublicado\nC\u00f3mo citar\nN\u00famero\nSecci\u00f3n\nLicencia\nCopyright\nANM de Colombia\nLos autores deben declarar revisi\u00f3n, validaci\u00f3n y aprobaci\u00f3n para publicaci\u00f3n del manuscrito, adem\u00e1s de la cesi\u00f3n de los derechos patrimoniales de publicaci\u00f3n, mediante un documento que debe ser enviado antes de la aparici\u00f3n del escrito. Puede solicitar el formato a trav\u00e9s del correo\n[revistamedicina@anmdecolombia.org.co ](mailto:revistamedicina@anmdecolombia.org.co) o descargarlo directamente [Documento Garant\u00edas y cesi\u00f3n de derechos.docx](/ojsanm/Documento Garant\u00edas y cesi\u00f3n de derechos.docx)\nCopyright\nANM de Colombia\nAuthors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent.", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttps://revistamedicina.net/index.php/Medicina/index\n\t\t\t\t\t", null, "https://revistamedicina.net/index.php/Medicina/issue/current", "http://anmdecolombia.net", "https://www.revistamedicina.net/index.php/Medicina/Directivos", "https://revistamedicina.net/index.php/Medicina/announcement", "https://revistamedicina.net/index.php/Medicina/2022", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/1", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/2", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/3", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/4", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/5", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/6", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/7", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/8", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/9", "https://revistamedicina.net/index.php/Medicina/1901", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/10", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/11", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/12", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/13", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/14", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/15", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/16", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/16", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/17", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/19", "https://revistamedicina.net/index.php/Medicina/1873", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/20", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/21", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/22", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/23", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/24", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/25", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/26", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/27", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/28", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/29", "https://www.revistamedicina.net/index.php/Medicina/issue/archive/30", "https://revistamedicina.net/index.php/Medicina/about", "https://revistamedicina.net/index.php/Medicina/about", "https://revistamedicina.net/index.php/Medicina/about/submissions", "https://revistamedicina.net/index.php/Medicina/about/editorialTeam", "https://revistamedicina.net/index.php/Medicina/about/contact", "https://revistamedicina.net/index.php/Medicina/es", "https://indice.revistamedicina.net/", "https://revistamedicina.net/index.php/Medicina/search", "https://revistamedicina.net/index.php/Medicina", "https://revistamedicina.net/", "https://revistamedicina.net/index.php/Medicina/user/register", "https://revistamedicina.net/index.php/Medicina/login", null, "https://revistamedicina.net/index.php/Medicina/index", "https://revistamedicina.net/index.php/Medicina/issue/archive", "https://revistamedicina.net/index.php/Medicina/issue/view/N99", "http://www.bdigital.unal", "https://revistamedicina.net/index.php/Medicina/article/view/99-4/163", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/acm-sig-proceedings?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/acs-nano?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/apa?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/chicago-author-date?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/harvard-cite-them-right?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/ieee?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/modern-language-association?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/get/vancouver?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/download/ris?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/citationstylelanguage/download/bibtex?submissionId=80&publicationId=73", "https://revistamedicina.net/index.php/Medicina/issue/view/N99", "mailto:revistamedicina@anmdecolombia.org.co", "/ojsanm/Documento Garant\u00edas y cesi\u00f3n de derechos.docx", "https://revistamedicina.net/index.php/Medicina/user/setLocale/es_ES?source=%2Findex.php%2FMedicina%2Farticle%2Fview%2F99-4", "https://revistamedicina.net/index.php/Medicina/user/setLocale/en_US?source=%2Findex.php%2FMedicina%2Farticle%2Fview%2F99-4", "https://revistamedicina.net/index.php/Medicina/about/submissions", "https://revistamedicina.net/index.php/Medicina/gateway/plugin/WebFeedGatewayPlugin/atom", "https://revistamedicina.net/index.php/Medicina/gateway/plugin/WebFeedGatewayPlugin/rss2", "https://revistamedicina.net/index.php/Medicina/gateway/plugin/WebFeedGatewayPlugin/rss", "/index.php/Medicina/libraryFiles/downloadPublic/18", "/index.php/Medicina/libraryFiles/downloadPublic/19", "/index.php/Medicina/libraryFiles/downloadPublic/20", "/index.php/Medicina/libraryFiles/downloadPublic/21", "/index.php/Medicina/libraryFiles/downloadPublic/22", "/index.php/Medicina/libraryFiles/downloadPublic/23", "/index.php/Medicina/libraryFiles/downloadPublic/11", "/index.php/Medicina/libraryFiles/downloadPublic/12", "/index.php/Medicina/libraryFiles/downloadPublic/13", "/index.php/Medicina/libraryFiles/downloadPublic/14", "/index.php/Medicina/libraryFiles/downloadPublic/15", "/index.php/Medicina/libraryFiles/downloadPublic/16", "/index.php/Medicina/libraryFiles/downloadPublic/17", "https://doaj.org/toc/2389-8356?source=%7B%22query%22%3A%7B%22filtered%22%3A%7B%22filter%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22term%22%3A%7B%22index.issn.exact%22%3A%222389-8356%22%7D%7D%2C%7B%22term%22%3A%7B%22_type%22%3A%22article%22%7D%7D%5D%7D%7D%2C%22query%22%3A%7B%22match_all%22%3A%7B%7D%7D%7D%7D%2C%22from%22%3A0%2C%22size%22%3A100%7D", "https://doaj.org/toc/2389-8356?source=%7B%22query%22%3A%7B%22filtered%22%3A%7B%22filter%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22term%22%3A%7B%22index.issn.exact%22%3A%222389-8356%22%7D%7D%2C%7B%22term%22%3A%7B%22_type%22%3A%22article%22%7D%7D%5D%7D%7D%2C%22query%22%3A%7B%22match_all%22%3A%7B%7D%7D%7D%7D%2C%22from%22%3A0%2C%22size%22%3A100%7D", "https://www.redib.org/recursos/Record/oai_revista1589-medicina-bogota", "http://lilacs.bvsalud.org/es/", "https://scienti.minciencias.gov.co/publindex/#/revistasPublindex/detalle?tipo=R&idRevista=390", "https://www.latindex.org/latindex/Solr/Busqueda?idModBus=0&buscar=0120-5498&submit=Buscar", "https://scholar.google.es/scholar?hl=es&as_sdt=0%2C5&q=%22Academia+Nacional+de+Medicina%22+%2B+%22anmdecolombia%22&btnG=", "https://portal.research4life.org/content/journals?value2=0120-5498&option2=fulltext&operator2=AND", "http://portalrev.enfermagem.bvs.br/index.php?issn=0120-5498&lang=pt", "http://www.imbiomed.com.mx/1/1/articulos.php?method=showIndex&id_revista=186", "https://encolombia.com/medicina/revistas-medicas/academedicina/", "http://www.ulrichsweb.com/ulrichsweb/faqs.asp", "https://catalog.nlm.nih.gov/discovery/fulldisplay?context=L&vid=01NLM_INST:01NLM_INST&search_scope=MyInstitution&tab=LibraryCatalog&lang=en&docid=alma997825093406676", "https://www.sprintknowledge.com/journal-details/2389-8356", "http://www.worldcat.org/title/medicina-organo-informativo-de-la-academia-nacional-de-medicina-de-colombia/oclc/47813832&referer=brief_results", "https://www.heal-link.gr/%ce%b7%ce%bb%ce%b5%ce%ba%cf%84%cf%81%ce%bf%ce%bd%ce%b9%ce%ba%ce%ac-%cf%80%ce%b5%cf%81%ce%b9%ce%bf%ce%b4%ce%b9%ce%ba%ce%ac-%ce%b1%ce%bd%ce%ac-%cf%84%ce%af%cf%84%ce%bb%ce%bf/", "https://www.gfmer.ch/Medical_journals/Revistas_medicas_acceso_libre.htm", "http://www.ingentaconnect.com/content/doaj/01205498", "/ojsanm/index.php/Medicina/issue/archive", "https://creativecommons.org/licenses/by-nc-nd/2.5/co/", "https://creativecommons.org/licenses/by-nc-nd/2.5/co/", "/index.php/Medicina/es", "/index.php/Medicina/es", null, "https://revistamedicina.net/index.php/Medicina/about/aboutThisPublishingSystem"]}